Obstetric Racial Disparities in the Era of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial and the Coronavirus Disease 2019 (COVID-19) Pandemic
CONCLUSION: Changes in obstetric practice after both the ARRIVE trial and the COVID-19 pandemic were not associated with changes in Black-White racial differences in labor induction, cesarean delivery, and pregnancy-associated hypertension.PMID:38547489 | DOI:10.1097/AOG.0000000000005564 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - March 28, 2024 Category: OBGYN Authors: Sarahn M Wheeler Tracy Truong Shakthi Unnithan Hwanhee Hong Evan Myers Geeta K Swamy Source Type: research
Obstetric Racial Disparities in the Era of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial and the Coronavirus Disease 2019 (COVID-19) Pandemic
CONCLUSION: Changes in obstetric practice after both the ARRIVE trial and the COVID-19 pandemic were not associated with changes in Black-White racial differences in labor induction, cesarean delivery, and pregnancy-associated hypertension.PMID:38547489 | DOI:10.1097/AOG.0000000000005564 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - March 28, 2024 Category: OBGYN Authors: Sarahn M Wheeler Tracy Truong Shakthi Unnithan Hwanhee Hong Evan Myers Geeta K Swamy Source Type: research
Obstetric Racial Disparities in the Era of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial and the Coronavirus Disease 2019 (COVID-19) Pandemic
CONCLUSION: Changes in obstetric practice after both the ARRIVE trial and the COVID-19 pandemic were not associated with changes in Black-White racial differences in labor induction, cesarean delivery, and pregnancy-associated hypertension.PMID:38547489 | DOI:10.1097/AOG.0000000000005564 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - March 28, 2024 Category: OBGYN Authors: Sarahn M Wheeler Tracy Truong Shakthi Unnithan Hwanhee Hong Evan Myers Geeta K Swamy Source Type: research
Comparison of Misoprostol with Foley Catheter vs Misoprostol alone for Cervical Ripening and Induction of Labor in Patients with Premature Rupture of Membrane: A Randomized Clinical Trial Study
CONCLUSION: An intracervical Foley catheter with misoprostol is more effective in inducing labor in pregnancies with premature rupture of the membranes than using misoprostol alone and can be a safe and effective option.PMID:38525402 | PMC:PMC10958730 | DOI:10.4103/abr.abr_78_23 (Source: Biomed Res)
Source: Biomed Res - March 25, 2024 Category: Research Authors: Seyyedeh Azam PoorHosseini Masoumeh Mirteimouri Maliheh RakhshaniFar Seyede Houra Mousavi Vahed Fedyeh Haghollahi Source Type: research
Comparison of Misoprostol with Foley Catheter vs Misoprostol alone for Cervical Ripening and Induction of Labor in Patients with Premature Rupture of Membrane: A Randomized Clinical Trial Study
CONCLUSION: An intracervical Foley catheter with misoprostol is more effective in inducing labor in pregnancies with premature rupture of the membranes than using misoprostol alone and can be a safe and effective option.PMID:38525402 | PMC:PMC10958730 | DOI:10.4103/abr.abr_78_23 (Source: Adv Data)
Source: Adv Data - March 25, 2024 Category: Epidemiology Authors: Seyyedeh Azam PoorHosseini Masoumeh Mirteimouri Maliheh RakhshaniFar Seyede Houra Mousavi Vahed Fedyeh Haghollahi Source Type: research
Comparison of Misoprostol with Foley Catheter vs Misoprostol alone for Cervical Ripening and Induction of Labor in Patients with Premature Rupture of Membrane: A Randomized Clinical Trial Study
CONCLUSION: An intracervical Foley catheter with misoprostol is more effective in inducing labor in pregnancies with premature rupture of the membranes than using misoprostol alone and can be a safe and effective option.PMID:38525402 | PMC:PMC10958730 | DOI:10.4103/abr.abr_78_23 (Source: Biomed Res)
Source: Biomed Res - March 25, 2024 Category: Research Authors: Seyyedeh Azam PoorHosseini Masoumeh Mirteimouri Maliheh RakhshaniFar Seyede Houra Mousavi Vahed Fedyeh Haghollahi Source Type: research
Comparison of Misoprostol with Foley Catheter vs Misoprostol alone for Cervical Ripening and Induction of Labor in Patients with Premature Rupture of Membrane: A Randomized Clinical Trial Study
CONCLUSION: An intracervical Foley catheter with misoprostol is more effective in inducing labor in pregnancies with premature rupture of the membranes than using misoprostol alone and can be a safe and effective option.PMID:38525402 | PMC:PMC10958730 | DOI:10.4103/abr.abr_78_23 (Source: Adv Data)
Source: Adv Data - March 25, 2024 Category: Epidemiology Authors: Seyyedeh Azam PoorHosseini Masoumeh Mirteimouri Maliheh RakhshaniFar Seyede Houra Mousavi Vahed Fedyeh Haghollahi Source Type: research
Outpatient labor induction —Exploring future potential by assessing eligibility in a historical cohort
ConclusionsIn this historical cohort, three in ten women met the criteria for outpatient management of labor induction with oral misoprostol. Serious adverse events were rare. The average time span from the initiation of labor induction to the last misoprostol was nearly 24 h. This suggests a potential for low-risk women with an induced labor to spend a substantial period of time at home before labor onset. However, larger studies testing or evaluating labor induction with oral misoprostol as an outpatient procedure are needed to draw conclusions. (Source: Acta Obstetricia et Gynecologica Scandinavica)
Source: Acta Obstetricia et Gynecologica Scandinavica - March 20, 2024 Category: OBGYN Authors: Kjersti Engen Marsdal,
Ingvil Krarup S ørbye,
Stine Bernitz,
Ranveig Elise T. Sve,
Kristine Ask,
Mirjam Lukasse Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
A singleton pregnancy with placental chorioangioma and hydrops fetalis complicated with mirror syndrome and ritodrine-induced side effects: a case report
We report a case complicate... (Source: BMC Pregnancy and Childbirth)
Source: BMC Pregnancy and Childbirth - March 20, 2024 Category: OBGYN Authors: Pei-Tzu Wu, Kun-Long Huang, Ching-Chang Tsai, Hsin-Hsin Cheng, Yun-Ju Lai and Te-Yao Hsu Tags: Case Report Source Type: research
In vitro inhibition of uterine contractions using electrospun nanofibers loaded with nifedipine and ML7
CONCLUSIONS: The results indicate that human uterine contractions can be inhibited using calcium channel blocker (nifedipine) and myosin light chain kinase inhibitor (ML7) loaded nanofibers in uterine tissue strips. These results strongly suggested the potential for the development of locally effective and safe controlled drug release systems to prevent premature birth.PMID:38497872 | DOI:10.26355/eurrev_202403_35603 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 18, 2024 Category: Drugs & Pharmacology Authors: Y Karasu M Demeli Ertu ş D Önal B Top çu H Ero ğlu B Pehlivano ğlu Source Type: research
In vitro inhibition of uterine contractions using electrospun nanofibers loaded with nifedipine and ML7
CONCLUSIONS: The results indicate that human uterine contractions can be inhibited using calcium channel blocker (nifedipine) and myosin light chain kinase inhibitor (ML7) loaded nanofibers in uterine tissue strips. These results strongly suggested the potential for the development of locally effective and safe controlled drug release systems to prevent premature birth.PMID:38497872 | DOI:10.26355/eurrev_202403_35603 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - March 18, 2024 Category: Drugs & Pharmacology Authors: Y Karasu M Demeli Ertu ş D Önal B Top çu H Ero ğlu B Pehlivano ğlu Source Type: research
In vitro inhibition of uterine contractions using electrospun nanofibers loaded with nifedipine and ML7
CONCLUSIONS: The results indicate that human uterine contractions can be inhibited using calcium channel blocker (nifedipine) and myosin light chain kinase inhibitor (ML7) loaded nanofibers in uterine tissue strips. These results strongly suggested the potential for the development of locally effective and safe controlled drug release systems to prevent premature birth.PMID:38497872 | DOI:10.26355/eurrev_202403_35603 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 18, 2024 Category: Drugs & Pharmacology Authors: Y Karasu M Demeli Ertu ş D Önal B Top çu H Ero ğlu B Pehlivano ğlu Source Type: research
In vitro inhibition of uterine contractions using electrospun nanofibers loaded with nifedipine and ML7
CONCLUSIONS: The results indicate that human uterine contractions can be inhibited using calcium channel blocker (nifedipine) and myosin light chain kinase inhibitor (ML7) loaded nanofibers in uterine tissue strips. These results strongly suggested the potential for the development of locally effective and safe controlled drug release systems to prevent premature birth.PMID:38497872 | DOI:10.26355/eurrev_202403_35603 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - March 18, 2024 Category: Drugs & Pharmacology Authors: Y Karasu M Demeli Ertu ş D Önal B Top çu H Ero ğlu B Pehlivano ğlu Source Type: research
In vitro inhibition of uterine contractions using electrospun nanofibers loaded with nifedipine and ML7
CONCLUSIONS: The results indicate that human uterine contractions can be inhibited using calcium channel blocker (nifedipine) and myosin light chain kinase inhibitor (ML7) loaded nanofibers in uterine tissue strips. These results strongly suggested the potential for the development of locally effective and safe controlled drug release systems to prevent premature birth.PMID:38497872 | DOI:10.26355/eurrev_202403_35603 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 18, 2024 Category: Drugs & Pharmacology Authors: Y Karasu M Demeli Ertu ş D Önal B Top çu H Ero ğlu B Pehlivano ğlu Source Type: research
In vitro inhibition of uterine contractions using electrospun nanofibers loaded with nifedipine and ML7
CONCLUSIONS: The results indicate that human uterine contractions can be inhibited using calcium channel blocker (nifedipine) and myosin light chain kinase inhibitor (ML7) loaded nanofibers in uterine tissue strips. These results strongly suggested the potential for the development of locally effective and safe controlled drug release systems to prevent premature birth.PMID:38497872 | DOI:10.26355/eurrev_202403_35603 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - March 18, 2024 Category: Drugs & Pharmacology Authors: Y Karasu M Demeli Ertu ş D Önal B Top çu H Ero ğlu B Pehlivano ğlu Source Type: research
